Ignite Creation Date:
2024-10-25 @ 7:58 PM
Last Modification Date:
2024-10-26 @ 3:36 PM
Study NCT ID:
NCT06533280
Status:
SUSPENDED
Last Update Posted:
None
First Post:
2024-07-29
Brief Title:
VH3739937 Phase 1 Multiple Ascending Dose MAD Study in Healthy Volunteers Including Relative Bioavailability RBA Optional Food Effect FE and Drug-drug Interaction DDI
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Multi-part Phase 1 Study Assessing the Safety Tolerability and PK of VH3739937 in Healthy Participants by Conducting MAD and RBA Cohorts With Optional Food Effect and Drug Interaction Cohorts
Status:
SUSPENDED
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Based on preliminary findings in a preclinical study of a similar maturation inhibitor ViiV Healthcare have taken the decision to place the study 221773 of maturation inhibitor VH3739937 on temporary halt
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will assess safety tolerability and pharmacokinetic PK of VH3739937 in healthy participants
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None